GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » YoY EPS Growth

Enwei Pharmaceutical Co (SZSE:301331) YoY EPS Growth : -73.52% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enwei Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Enwei Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Jun. 2024 was -73.52%.

Enwei Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was ¥0.09.


Enwei Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for Enwei Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enwei Pharmaceutical Co YoY EPS Growth Chart

Enwei Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial -6.35 27.33 -3.26 -38.49 3.48

Enwei Pharmaceutical Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.09 -38.64 -23.67 -69.29 -73.52

Enwei Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Enwei Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(0.832-0.804)/ | 0.804 |
=3.48 %

Enwei Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EPS Growth (Q: Jun. 2024 )
=(Earnings per Share (Diluted) (Q: Jun. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(0.094-0.355)/ | 0.355 |
=-73.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enwei Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Enwei Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Enwei Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.

Enwei Pharmaceutical Co Headlines

No Headlines